BCLSI
IPSC icon

Bain Capital Life Sciences Investors’s Century Therapeutics IPSC Stock Holding History

Bain Capital Life Sciences Investors’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,538,609
Closed -$1.76M – 21
2025
Q3 		$1.76M Sell
3,538,609
-1,871,752
-35% -$1.01M 0.12% 20
2025
Q2 		$3.02M Hold
5,410,361
– – 0.38% 18
2025
Q1 		$2.58M Hold
5,410,361
– – 0.38% 20
2024
Q4 		$5.46M Hold
5,410,361
– – 0.64% 19
2024
Q3 		$9.25M Hold
5,410,361
– – 0.96% 14
2024
Q2 		$13.8M Buy
+5,410,361
New +$17.1M 1.51% 13

Other funds holding IPSC

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return